Jun 02, 2020 / 02:00PM GMT
David Howard Windley - Jefferies LLC, Research Division - MD & Equity Analyst
Hello and good morning. My name is Dave Windley. I'm Managing Director with Jefferies Healthcare Equity Research Department. I want to thank you, our audience, for attending our Virtual Healthcare Conference this year as well as our next company.
It is my pleasure to introduce Jim Foster, and he's Chairman, President and CEO of Charles River Laboratories, and they are our next presenting company. I want to remind you that we are taking questions through the chat function of our interface. So feel free to send questions through that portal, and we will try to address those toward the end.
I'll launch here by just prefacing that Charles River did have a very, very strong first quarter and stocks reacted, obviously, very well from that, led by revenue and margin performance in both its DSA and Manufacturing Support segments. I'm going to let -- hand it over to Jim Foster to give some opening remarks about the company's recent performance and strategy, and then we'll dig into some questions. So Jim, go ahead,
Charles River Laboratories International Inc at Jefferies Healthcare Conference (Virtual) Transcript
Jun 02, 2020
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers